Senior Vice President, Pharmacology
Current
May 2024 - Present
AeroLeads people directory · profile
Mark Stroh Email & Phone Number
SVP | Head Translational and Quantitative Clinical Pharmacology | Cross Functional Leader | Biotech | Driving pre-IND Through Late-Stage Development | San Francisco, CA | Cambridge, MA
at
Metsera
1 work email found
@intelliatx.com
2 phones found area 805
LinkedIn matched
✓ Verified Jun 2026
4 data sources
Profile completeness 100%
Current company
Role
SVP | Head Translational and Quantitative Clinical Pharmacology | Cross Functional Leader | Biotech | Driving pre-IND Through Late-Stage Development | San Francisco, CA | Cambridge, MA
Location
United States, United States, United States
Who is Mark Stroh? Overview
A concise factual answer block for searchers comparing this professional profile.
Quick answer
Mark Stroh is listed as SVP | Head Translational and Quantitative Clinical Pharmacology | Cross Functional Leader | Biotech | Driving pre-IND Through Late-Stage Development | San Francisco, CA | Cambridge, MA at Metsera, based in United States, United States, United States. AeroLeads shows a work email signal at intelliatx.com, phone signal with area code 805, and a matched LinkedIn profile for Mark Stroh.
Mark Stroh previously worked as Senior Vice President, Pharmacology at Metsera and Vice President and Head, Clinical Pharmacology at Intellia Therapeutics, Inc.. Mark Stroh holds Phd, Chemical Engineering from Cornell University.
Company email context
Email format at Metsera
This section adds company-level context without repeating Mark Stroh's masked contact details.
{first}.{last}@intelliatx.com
86% confidence
AeroLeads found 1 current-domain work email signal for Mark Stroh. Compare company email patterns before reaching out.
Profile bio
About Mark Stroh
I am an experienced leader in Translational and Quantitative Clinical Pharmacology supporting pre-IND through Phase 3 and post-marketing development of small molecules, biologics, and novel formats across several disease areas including oncology, neurology, endocrine, cardiovascular, infectious disease, and rare disease. Where I excel:• Building and leading technical teams • Cross functional leadership• Model informed drug development• Driving successful INDs, NDAs, and BLAsHighlights:• Demonstrated record of team building and mentorship, with significant experience building new functions from the ground up • Champion of effective teamwork in developing a wide array of modalities, including small molecule, biologics, and novel format> Small Molecule: Key contributor to FIH-Phase 3, DDI, ADME, biopharmaceutic, and special population study protocols and CSRs.> Biologics: Both functional area lead and cross-functional accountable (Pharmacology Subteam Leader) roles for approval of TECENTRIQ® (atezolizumab) valued at $2.68 billion in 2023. > Novel Format: Functional area head for multiple monoclonal, ADC, and TCB prodrug INDs.> Novel format: Functional area head for the first ever systemically administered CRISPR therapies.Specialties:Cross-Disciplinary Leadership; Drug Development & Clinical Trials; Clinical Pharmacology; Translational Sciences; Team Building & Leadership; Model Informed Drug Development; Small Molecule Therapies; ADME; DDI; Special Populations; Biopharmaceutics; Biologics; Immunotherapies; Immunogenicity; Novel Format; Prodrugs; CRISPR; Genome Editing; Regulatory Interactions; IND; NDA/ BLA; Executive Presentations; Project & Vendor Management; Partnerships & Collaboration
Listed skills include Drug Development, Pharmacokinetics, Pharmacodynamics, Drug Discovery, and 44 others.
Current workplace
Mark Stroh's current company
Company context helps verify the profile and gives searchers a useful next step.
5 roles
Mark Stroh work experience
A career timeline built from the work history available for this profile.
Vice President And Head, Clinical Pharmacology
Built and led lead company’s first Quantitative Clinical Pharmacology department in support of multiple ex vivo and in vivo CRISPR therapies in rare disease and oncology. Capabilities of the department included clinical pharmacology, pharmacometrics, and QSP. Team utilized model informed drug development to facilitate advancement of the first ever.
Apr 2021 - Jan 2024
Vice President And Head, Clinical Pharmacology, Qsp, And Pharmacometrics
Formed and led company’s first Quantitative Clinical Pharmacology department with capabilities that encompassed clinical pharmacology, QSP, and pharmacometrics. Team informed robust translation across the entire portfolio of first-of-kind antibody prodrug assets (i.e. monocolonal, ADC, and TCB prodrugs) using a common model-based approach in the absence of.
Nov 2016 - Mar 2021
Senior Scientist, Clinical Pharmacology
Provided direct and supervisory support of multiple assets in oncology and infectious disease with later emphasis in cancer immunotherapy. Both Clinical Pharmacology lead and Pharmacology Subteam Lead for first approval of TECENTRIQ® (atezolizumab). Formulated successful Clinical Pharmacology strategy for development of multiple cancer immunotherapy assets.
Oct 2012 - Oct 2016
Senior Investigator, Clinical Pk/Pd
Merck
Provided supervisory and direct support for preclinical to late-stage peptide, monoclonal, siRNA, and small molecule programs. Key contributor to FIH-Phase 3, DDI, ADME, biopharmaceutic, and special population study protocols and CSRs. Worked in neurology, endocrine, and cardiovascular disease areas with increasing emphasis in oncology. Served as.
Nov 2004 - Jun 2011
3 education records
Mark Stroh education
Phd, Chemical Engineering
Cornell University
Bs, Chemical Engineering
University Of California, Berkeley
Postdoctoral Fellow
Harvard Medical School
FAQ
Frequently asked questions about Mark Stroh
Quick answers generated from the profile data available on this page.
What company does Mark Stroh work for?
Mark Stroh works for Metsera.
What is Mark Stroh's role at Metsera?
Mark Stroh is listed as SVP | Head Translational and Quantitative Clinical Pharmacology | Cross Functional Leader | Biotech | Driving pre-IND Through Late-Stage Development | San Francisco, CA | Cambridge, MA at Metsera.
What is Mark Stroh's email address?
AeroLeads has found 1 work email signal at @intelliatx.com for Mark Stroh at Metsera.
What is Mark Stroh's phone number?
AeroLeads has found 2 phone signal(s) with area code 805 for Mark Stroh at Metsera.
Where is Mark Stroh based?
Mark Stroh is based in United States, United States, United States while working with Metsera.
What companies has Mark Stroh worked for?
Mark Stroh has worked for Metsera, Intellia Therapeutics, Inc., Cytomx Therapeutics, Genentech, and Merck.
How can I contact Mark Stroh?
You can use AeroLeads to view verified contact signals for Mark Stroh at Metsera, including work email, phone, and LinkedIn data when available.
What schools did Mark Stroh attend?
Mark Stroh holds Phd, Chemical Engineering from Cornell University.
What skills is Mark Stroh known for?
Mark Stroh is listed with skills including Drug Development, Pharmacokinetics, Pharmacodynamics, Drug Discovery, Clinical Development, Clinical Pharmacology, Pharmaceutical Industry, and Drug Metabolism.
Find 750M verified contacts
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial